Dr. Prasad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
510 S Kingshighway Blvd
Dept Radiology
Saint Louis, MO 63110Phone+1 314-362-7200Fax+1 314-747-4189
Education & Training
MGM Medical College IndoreClass of 2001
Clinical Trials
- Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE Start of enrollment: 2021 Dec 21
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 57 citationsEuropean Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease.Simona Grozinsky-Glasberg, Joseph Davar, Johannes Hofland, Rebecca Dobson, Vikas Prasad
Journal of Neuroendocrinology. 2022-07-01 - 5 citationsWhat Animal Cancers teach us about Human Biology.Patricia Kattner, Katharina Zeiler, Verena J. Herbener, Katia La Ferla-Brühl, Rebecca Kassubek
Theranostics. 2021-05-03 - 14 citationsPredictive and prognostic potential of pretreatmentGa-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer treated with ...Majid Assadi, Reyhaneh Manafi-Farid, Esmail Jafari, Ahmad Keshavarz, GhasemAli Divband
Frontiers in Oncology. 2022-01-01
Press Mentions
FAPI-PET/CT Superior to FDG-PET/CT in Assessing Liver CancerNovember 18th, 2024- New PET Tracer Shows Promise in Patients with Kidney CancerNovember 14th, 2024
- Hermes Medical Gets FDA Nod for Latest SoftwareNovember 13th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
